Letters POPADAD trial Don’t stop taking aspirin BMJ 2008; 337 doi: https://doi.org/10.1136/bmj.a2581 (Published 19 November 2008) Cite this as: BMJ 2008;337:a2581 Article Related content Metrics Responses Peer review Related articles Education And Debate Joint British recommendations on prevention of coronary heart disease in clinical practice: summary Published: 11 March 2000; BMJ 320 doi:10.1136/bmj.320.7236.705 Research The prevention of progression of arterial disease and diabetes (POPADAD) trial: factorial randomised placebo controlled trial of aspirin and antioxidants in patients with diabetes and asymptomatic peripheral arterial disease Published: 16 October 2008; BMJ 337 doi:10.1136/bmj.a1840 See more Type 1 diabetes: Randox removes adverts after claims that it was using fear to sell genetic test BMJ March 25, 2024, 384 q744; DOI: https://doi.org/10.1136/bmj.q744 FDA approves first over-the-counter blood glucose monitor for diabetes BMJ March 11, 2024, 384 q611; DOI: https://doi.org/10.1136/bmj.q611 US food manufacturer can say that eating yogurt reduces risk of type 2 diabetes, says FDA BMJ March 06, 2024, 384 q569; DOI: https://doi.org/10.1136/bmj.q569 Scarlett McNally: Preventing obesity is different from curing it—and even more urgent BMJ January 23, 2024, 384 q134; DOI: https://doi.org/10.1136/bmj.q134 Artificial pancreases for type 1 diabetes: Better access is “watershed moment”—but delivery is key BMJ January 23, 2024, 384 q102; DOI: https://doi.org/10.1136/bmj.q102
